8/31/2025

Janusmed fosterpåverkan

Janusmed fosterpåverkan – tetrahydrocannabinol

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Cannabis sativa

Cannabis sativa

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Jazz Pharmaceuticals Ireland Limited. Sativex. Produktresumé. Läkemedelsverket [www]. [updated 2024-10-04, cited 2025-06-30].

  2. FDA. Marinol. FDA [www]. [updated 2004-09-01, cited 2025-06-30].

  3. UK Teratology Information Service (UKTIS). Use of Cannabis in pregnancy. July 2018 Version 2. UKTIS [www]. [cited 2025-06-30].

  4. Reprotox. Cannabis. Micromedex [www]. [cited 2025-06-30].

  5. Luke S, Hobbs AJ, Smith M, Riddell C, Murphy P, Agborsangaya C et al. Cannabis use in pregnancy and maternal and infant outcomes: A Canadian cross-jurisdictional population-based cohort study. PLoS One. 2022;17(11):e0276824.

  6. Delker E, Hayes S, Kelly AE, Jones KL, Chambers C, Bandoli G. Prenatal Exposure to Cannabis and Risk of Major Structural Birth Defects: A Systematic Review and Meta-analysis. Obstet Gynecol. 2023;142(2):269-283.

  7. Duko B, Dachew BA, Pereira G, Alati R. The effect of prenatal cannabis exposure on offspring preterm birth: a cumulative meta-analysis. Addiction. 2023;118(4):607-619.

  8. Bandoli G, Jelliffe-Pawlowski L, Schumacher B, Baer RJ, Felder JN, Fuchs JD et al. Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes. Drug Alcohol Depend. 2021;225:108757.

  9. Ayonrinde OT, Ayonrinde OA, Van Rooyen D, Tait R, Dunn M, Mehta S et al. Association between gestational cannabis exposure and maternal, perinatal, placental, and childhood outcomes. J Dev Orig Health Dis. 2021;12(5):694-703.

  10. Bailey A, Kerr W, Alhay Z, Rom M, Hamilton S, Campbell J et al. Fetal Cannabis Exposure and Neonatal Outcomes: A Systematic Review and Meta-Analysis. Matern Child Health J. 2025;29(5):703-713.

  11. Goldschmidt L, Richardson GA, Willford JA, Severtson SG, Day NL. School achievement in 14-year-old youths prenatally exposed to marijuana. Neurotoxicol Teratol. 2012;34(1):161-7.

  12. DrugBank Onlie. Medical Cannabis: Uses, Interactions, Mechanism of Action. DrugBank [www]. [cited 2025-06-30].

  1. Jazz Pharmaceuticals Ireland Limited. Sativex. Produktresumé. Läkemedelsverket [www]. [updated 2024-10-04, cited 2025-06-30].
  2. FDA. Marinol. FDA [www]. [updated 2004-09-01, cited 2025-06-30].
  3. UK Teratology Information Service (UKTIS). Use of Cannabis in pregnancy. July 2018 Version 2. UKTIS [www]. [cited 2025-06-30].
  4. Reprotox. Cannabis. Micromedex [www]. [cited 2025-06-30].
  5. Luke S, Hobbs AJ, Smith M, Riddell C, Murphy P, Agborsangaya C et al. Cannabis use in pregnancy and maternal and infant outcomes: A Canadian cross-jurisdictional population-based cohort study. PLoS One. 2022;17(11):e0276824.
  6. Delker E, Hayes S, Kelly AE, Jones KL, Chambers C, Bandoli G. Prenatal Exposure to Cannabis and Risk of Major Structural Birth Defects: A Systematic Review and Meta-analysis. Obstet Gynecol. 2023;142(2):269-283.
  7. Duko B, Dachew BA, Pereira G, Alati R. The effect of prenatal cannabis exposure on offspring preterm birth: a cumulative meta-analysis. Addiction. 2023;118(4):607-619.
  8. Bandoli G, Jelliffe-Pawlowski L, Schumacher B, Baer RJ, Felder JN, Fuchs JD et al. Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes. Drug Alcohol Depend. 2021;225:108757.
  9. Ayonrinde OT, Ayonrinde OA, Van Rooyen D, Tait R, Dunn M, Mehta S et al. Association between gestational cannabis exposure and maternal, perinatal, placental, and childhood outcomes. J Dev Orig Health Dis. 2021;12(5):694-703.
  10. Bailey A, Kerr W, Alhay Z, Rom M, Hamilton S, Campbell J et al. Fetal Cannabis Exposure and Neonatal Outcomes: A Systematic Review and Meta-Analysis. Matern Child Health J. 2025;29(5):703-713.
  11. Goldschmidt L, Richardson GA, Willford JA, Severtson SG, Day NL. School achievement in 14-year-old youths prenatally exposed to marijuana. Neurotoxicol Teratol. 2012;34(1):161-7.
  12. DrugBank Onlie. Medical Cannabis: Uses, Interactions, Mechanism of Action. DrugBank [www]. [cited 2025-06-30].